$953 Million is the total value of Novo Holdings A/S's 18 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 29.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VTI | Sell | VANGUARD INDEX FDStotal stk mkt | $230,941,000 | -22.3% | 2,155,100 | -24.0% | 24.24% | -25.6% |
| OPHT | Sell | OPHTHOTECH CORP | $184,243,000 | -11.2% | 3,610,487 | -26.5% | 19.34% | -15.0% |
| INGN | INOGEN INC | $177,856,000 | +11.4% | 3,549,320 | 0.0% | 18.67% | +6.7% | |
| VGK | VANGUARD INTL EQUITY INDEX Fftse europe etf | $98,033,000 | -3.8% | 2,101,000 | 0.0% | 10.29% | -7.9% | |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $66,513,000 | – | 3,367,763 | +100.0% | 6.98% | – |
| CRVS | Buy | CORVUS PHARMACEUTICALS INC | $45,975,000 | +0.5% | 3,224,046 | +2.2% | 4.83% | -3.7% |
| TBRA | Sell | TOBIRA THERAPEUTICS INC | $25,460,000 | +36.4% | 2,027,091 | -11.1% | 2.67% | +30.7% |
| CLCD | COLUCID PHARMACEUTICALS INC | $24,972,000 | +31.8% | 3,056,563 | 0.0% | 2.62% | +26.2% | |
| XLRN | Buy | ACCELERON PHARMA INC | $23,306,000 | +31.2% | 685,863 | +1.9% | 2.45% | +25.7% |
| SPNC | Buy | SPECTRANETICS CORP | $20,899,000 | +507.7% | 1,117,002 | +371.7% | 2.19% | +482.0% |
| FLXN | New | FLEXION THERAPEUTICS INC | $14,224,000 | – | 950,161 | +100.0% | 1.49% | – |
| MRUS | New | MERUS N V | $11,269,000 | – | 1,410,417 | +100.0% | 1.18% | – |
| IVTY | Buy | INVUITY INC | $10,249,000 | +51.6% | 1,075,448 | +14.9% | 1.08% | +45.2% |
| NBRV | Buy | NABRIVA THERAPEUTICS AG | $7,911,000 | +0.9% | 1,054,823 | +20.6% | 0.83% | -3.4% |
| WMGIZ | WRIGHT MED GROUP N Vright 03/01/2019 | $5,824,000 | +0.8% | 4,622,032 | 0.0% | 0.61% | -3.5% | |
| HTGM | HTG MOLECULAR DIAGNOSTICS INC | $3,482,000 | -5.2% | 1,280,185 | 0.0% | 0.37% | -9.2% | |
| XENE | XENON PHARMACEUTICALS INC | $753,000 | -15.6% | 127,563 | 0.0% | 0.08% | -19.4% | |
| TKAI | Sell | TOKAI PHARMACEUTICALS INC | $711,000 | -73.1% | 128,993 | -72.6% | 0.08% | -74.1% |
| GKOS | Exit | GLAUKOS CORP | $0 | – | -101,106 | -100.0% | -0.19% | – |
| PEN | Exit | PENUMBRA, INC. | $0 | – | -263,191 | -100.0% | -1.33% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 41 | Q3 2022 | 64.7% |
| INOGEN INC | 34 | Q2 2022 | 68.8% |
| VANGUARD INTL EQUITY INDEX F | 29 | Q4 2016 | 37.6% |
| AMICUS THERAPEUTICS INC | 22 | Q3 2023 | 4.1% |
| AKEBIA THERAPEUTICS INC | 21 | Q3 2020 | 4.8% |
| VERONA PHARMA PLC | 21 | Q2 2022 | 1.9% |
| CORVUS PHARMACEUTICALS INC | 20 | Q4 2020 | 7.1% |
| INSPIRE MED SYS INC | 20 | Q3 2023 | 1.8% |
| CABLE ONE INC | 19 | Q3 2023 | 9.7% |
| FLEXION THERAPEUTICS INC | 19 | Q3 2021 | 4.7% |
View Novo Holdings A/S's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyteir Therapeutics, Inc. | August 03, 2023 | 1,547,136 | 4.4% |
| Disc Medicine, Inc. | June 28, 2023 | 1,090,772 | 4.8% |
| Galera Therapeutics, Inc. | June 28, 2023 | 2,100,000 | 4.9% |
| VectivBio Holding AGSold out | May 26, 2023 | 0 | 0.0% |
| LanzaTech Global, Inc. | February 17, 2023 | 15,814,845 | 8.1% |
| Bolt Biotherapeutics, Inc.Sold out | January 04, 2023 | 0 | 0.0% |
| Arcellx, Inc. | December 12, 2022 | 1,750,000 | 4.0% |
| MINERVA SURGICAL INC | November 03, 2022 | 1,322,473 | 4.5% |
| Milestone Pharmaceuticals Inc. | October 24, 2022 | 1,378,538 | 4.6% |
| Galecto, Inc. | September 30, 2022 | 2,497,791 | 9.8% |
View Novo Holdings A/S's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-03-28 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 144 | 2024-03-18 |
| 4 | 2024-03-18 |
| SC 13D/A | 2024-03-18 |
| 144 | 2024-03-14 |
| SC 13D/A | 2024-03-07 |
View Novo Holdings A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.